77 related articles for article (PubMed ID: 12197698)
1. Differing Perspectives on Breast Cancer Chemoprevention.
Cuzick J; Wickerham L; Powles T
JAMA Oncol; 2016 Feb; 2(2):276-7. PubMed ID: 26869000
[No Abstract] [Full Text] [Related]
2. Sustained, local delivery of the PARP inhibitor talazoparib prevents the development of mammary gland hyperplasia in Brca1-deficient mice.
Zhang D; Singh B; Moerland J; Mitchell O; Lockwood L; Carapellucci S; Sridhar S; Liby KT
Sci Rep; 2021 Jan; 11(1):1234. PubMed ID: 33441637
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer prevention in women with a BRCA1 or BRCA2 mutation.
Metcalfe KA; Narod SA
Open Med; 2007; 1(3):e184-90. PubMed ID: 21673951
[No Abstract] [Full Text] [Related]
4. Weighing the risks and benefits of tamoxifen.
Greiver M
CMAJ; 2003 Jan; 168(1):12-3; discussion 13. PubMed ID: 12515774
[No Abstract] [Full Text] [Related]
5. Breast cancer prevention with tamoxifen.
Haden K; Santen R
Lippincotts Prim Care Pract; 2000; 4(4):434-40. PubMed ID: 11261120
[No Abstract] [Full Text] [Related]
6. [-Results of ongoing breast cancer prevention studies-].
Jungi WF
Arch Gynecol Obstet; 1995; 256 Suppl():S116-21. PubMed ID: 8619644
[No Abstract] [Full Text] [Related]
7. Tamoxifen for breast cancer prevention: safety warning.
Wooltorton E
CMAJ; 2002 Aug; 167(4):378-9. PubMed ID: 12197698
[No Abstract] [Full Text] [Related]
8. Give us clear, not convoluted, clinical practice guidelines.
Sehmer J
CMAJ; 2001 Nov; 165(11):1468-9. PubMed ID: 11762568
[No Abstract] [Full Text] [Related]
9. Tamoxifen: preventing breast cancer and placing the risk of deep vein thrombosis in perspective.
Goldhaber SZ
Circulation; 2005 Feb; 111(5):539-41. PubMed ID: 15699272
[No Abstract] [Full Text] [Related]
10. Task force cautious about chemoprevention. Official guidelines are out about taking tamoxifen and raloxifene to prevent breast cancer. These drugs can help, but they aren't for everyone.
Harv Womens Health Watch; 2002 Oct; 10(2):1-2. PubMed ID: 12393316
[No Abstract] [Full Text] [Related]
11. Venous thromboembolic disease and stroke in women taking tamoxifen for breast cancer chemoprevention.
Isaacs C
Clin Adv Hematol Oncol; 2005 Dec; 3(12):913-4. PubMed ID: 16555431
[No Abstract] [Full Text] [Related]
12. Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction.
Melnikow J; Paterniti D; Azari R; Kuenneth C; Birch S; Kuppermann M; Nuovo J; Keyzer J; Henderson S
Cancer; 2005 May; 103(10):1996-2005. PubMed ID: 15825209
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease.
Collaborative Group on Hormonal Factors in Breast Cancer
Lancet; 2002 Jul; 360(9328):187-95. PubMed ID: 12133652
[TBL] [Abstract][Full Text] [Related]
14. Hormone replacement therapy in relation to breast cancer.
Chen CL; Weiss NS; Newcomb P; Barlow W; White E
JAMA; 2002 Feb; 287(6):734-41. PubMed ID: 11851540
[TBL] [Abstract][Full Text] [Related]
15. Clinical practice guidelines for the care and treatment of breast cancer: the management of ductal carcinoma in situ (summary of the 2001 update).
Olivotto I; Levine M;
CMAJ; 2001 Oct; 165(7):912-3. PubMed ID: 11599333
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
